| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.0M | +65.6% |
| Cost of Revenue | $1.6M | +48.0% |
| Gross Profit | $2.4M | +80.4% |
| R&D Expense | $4.0M | +139.3% |
| SG&A Expense | $16.7M | +49.4% |
| Operating Income | -$18.3M | -58.8% |
| Interest Expense | $282K | — |
| Net Income | -$19.4M | -63.2% |
| EPS (Basic) | -$0.18 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.3M | -30.5% |
| Inventory | $2.0M | +925.6% |
| Current Assets | $15.7M | -0.2% |
| Total Assets | $23.6M | +22.9% |
| Current Liabilities | $9.7M | +293.8% |
| Total Liabilities | $13.1M | +358.2% |
| Stockholders' Equity | $10.5M | -35.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.4M | -155.0% |
| Capital Expenditures | $2.7M | +600.0% |
| Investing Cash Flow | -$4.6M | -69.8% |
| Financing Cash Flow | $17.5M | +12.5% |
| Free Cash Flow | -$20.0M | -178.7% |
| -20.0% |
| EPS (Diluted) | -$0.18 | -20.0% |